Dr. John Eberth is the founder of Equus Analytics, a leading equine genetics consultancy that applies advanced genomic science to support decision-making in the Thoroughbred industry. With a lifelong connection to horses and a deep academic background in biology and genetics, Dr. Eberth brings a rare combination of scientific expertise and practical equine understanding to his work.
Based in Kentucky, Dr. Eberth holds a BA in Biology from DePauw University and earned his MS in Genetics at the Gluck Equine Research Center at the University of Kentucky. His graduate research identified multiple mutations in the aggrecan gene—an important structural protein in cartilage—associated with dwarfism in miniature horses. This discovery contributed to the development of diagnostic testing that helps breeders reduce inherited risk within the population.
At Equus Analytics, Dr. Eberth leads a program focused on genetic profiling, performance-aptitude evaluation, health-risk screening, and growth-trajectory modeling for young Thoroughbreds. His work helps breeders, owners, and consignors make informed decisions grounded in data, whether evaluating mating choices, monitoring development, or preparing horses for sales.
Dr. Eberth is known for translating complex genetic information into clear, actionable guidance. His insights support early developmental planning for weanlings and yearlings, ensuring that genetic potential is understood and aligned with training, management, and long-term goals. His combination of scientific rigor and practical horsemanship makes him a valued resource within the young-horse selection and development.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.